Infertility Drug Market Research Report By Drug Type (Hormonal Drugs, Non-Hormonal Drugs, Surgical Drugs, Assisted Reproductive Technology Drugs), By End User (Hospitals, Fertility Clinics, Homecare Settings), By Gender (Female, Male), By Route of Administration (Oral, Injectable, Topical) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. INFERTILITY DRUG MARKET, BY DRUG TYPE (USD BILLION)

6.1. Hormonal Drugs

6.2. Non-Hormonal Drugs

6.3. Surgical Drugs

6.4. Assisted Reproductive Technology Drugs

7. INFERTILITY DRUG MARKET, BY END USER (USD BILLION)

7.1. Hospitals

7.2. Fertility Clinics

7.3. Homecare Settings

8. INFERTILITY DRUG MARKET, BY GENDER (USD BILLION)

8.1. Female

8.2. Male

9. INFERTILITY DRUG MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)

9.1. Oral

9.2. Injectable

9.3. Topical

10. INFERTILITY DRUG MARKET, BY REGIONAL (USD BILLION)

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. UK

10.2.3. France

10.2.4. Russia

10.2.5. Italy

10.2.6. Spain

10.2.7. Rest of Europe

10.3. APAC

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Malaysia

10.3.6. Thailand

10.3.7. Indonesia

10.3.8. Rest of APAC

10.4. South America

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Argentina

10.4.4. Rest of South America

10.5. MEA

10.5.1. GCC Countries

10.5.2. South Africa

10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market share Analysis

11.4. Major Growth Strategy in the Infertility Drug Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Infertility Drug Market

11.7. Key developments and growth strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales and Operating Income

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. Merck KGaA

12.1.1. Financial Overview

12.1.2. Products Offered

12.1.3. Key Developments

12.1.4. SWOT Analysis

12.1.5. Key Strategies

12.2. Ferring Pharmaceuticals

12.2.1. Financial Overview

12.2.2. Products Offered

12.2.3. Key Developments

12.2.4. SWOT Analysis

12.2.5. Key Strategies

12.3. Anecova

12.3.1. Financial Overview

12.3.2. Products Offered

12.3.3. Key Developments

12.3.4. SWOT Analysis

12.3.5. Key Strategies

12.4. Teva Pharmaceutical Industries

12.4.1. Financial Overview

12.4.2. Products Offered

12.4.3. Key Developments

12.4.4. SWOT Analysis

12.4.5. Key Strategies

12.5. BristolMyers Squibb

12.5.1. Financial Overview

12.5.2. Products Offered

12.5.3. Key Developments

12.5.4. SWOT Analysis

12.5.5. Key Strategies

12.6. Reproductive Health Technologies

12.6.1. Financial Overview

12.6.2. Products Offered

12.6.3. Key Developments

12.6.4. SWOT Analysis

12.6.5. Key Strategies

12.7. Helsinn Healthcare

12.7.1. Financial Overview

12.7.2. Products Offered

12.7.3. Key Developments

12.7.4. SWOT Analysis

12.7.5. Key Strategies

12.8. AbbVie

12.8.1. Financial Overview

12.8.2. Products Offered

12.8.3. Key Developments

12.8.4. SWOT Analysis

12.8.5. Key Strategies

12.9. Eli Lilly and Company

12.9.1. Financial Overview

12.9.2. Products Offered

12.9.3. Key Developments

12.9.4. SWOT Analysis

12.9.5. Key Strategies

12.10. Sundia MediTech Company

12.10.1. Financial Overview

12.10.2. Products Offered

12.10.3. Key Developments

12.10.4. SWOT Analysis

12.10.5. Key Strategies

12.11. Bayer AG

12.11.1. Financial Overview

12.11.2. Products Offered

12.11.3. Key Developments

12.11.4. SWOT Analysis

12.11.5. Key Strategies

12.12. Novartis

12.12.1. Financial Overview

12.12.2. Products Offered

12.12.3. Key Developments

12.12.4. SWOT Analysis

12.12.5. Key Strategies

12.13. Millendo Therapeutics

12.13.1. Financial Overview

12.13.2. Products Offered

12.13.3. Key Developments

12.13.4. SWOT Analysis

12.13.5. Key Strategies

12.14. Irvine Scientific

12.14.1. Financial Overview

12.14.2. Products Offered

12.14.3. Key Developments

12.14.4. SWOT Analysis

12.14.5. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. NORTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 3. NORTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 4. NORTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 5. NORTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 6. NORTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 7. US INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 8. US INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 9. US INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 10. US INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 11. US INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 12. CANADA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 13. CANADA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 14. CANADA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 15. CANADA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 16. CANADA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 17. EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 18. EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 19. EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 20. EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 21. EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 22. GERMANY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 23. GERMANY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 24. GERMANY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 25. GERMANY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 26. GERMANY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 27. UK INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 28. UK INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 29. UK INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 30. UK INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 31. UK INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 32. FRANCE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 33. FRANCE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 34. FRANCE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 35. FRANCE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 36. FRANCE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 37. RUSSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 38. RUSSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 39. RUSSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 40. RUSSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 41. RUSSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 42. ITALY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 43. ITALY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 44. ITALY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 45. ITALY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 46. ITALY INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 47. SPAIN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 48. SPAIN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 49. SPAIN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 50. SPAIN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 51. SPAIN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 52. REST OF EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 53. REST OF EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 54. REST OF EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 55. REST OF EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 56. REST OF EUROPE INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 57. APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 58. APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 59. APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 60. APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 61. APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 62. CHINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 63. CHINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 64. CHINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 65. CHINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 66. CHINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 67. INDIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 68. INDIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 69. INDIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 70. INDIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 71. INDIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 72. JAPAN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 73. JAPAN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 74. JAPAN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 75. JAPAN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 76. JAPAN INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 77. SOUTH KOREA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 78. SOUTH KOREA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 79. SOUTH KOREA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 80. SOUTH KOREA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 81. SOUTH KOREA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 82. MALAYSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 83. MALAYSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 84. MALAYSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 85. MALAYSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 86. MALAYSIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 87. THAILAND INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 88. THAILAND INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 89. THAILAND INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 90. THAILAND INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 91. THAILAND INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 92. INDONESIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 93. INDONESIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 94. INDONESIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 95. INDONESIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 96. INDONESIA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 97. REST OF APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 98. REST OF APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 99. REST OF APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 100. REST OF APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 101. REST OF APAC INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 102. SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 103. SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 104. SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 105. SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 106. SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 107. BRAZIL INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 108. BRAZIL INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 109. BRAZIL INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 110. BRAZIL INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 111. BRAZIL INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 112. MEXICO INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 113. MEXICO INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 114. MEXICO INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 115. MEXICO INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 116. MEXICO INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 117. ARGENTINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 118. ARGENTINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 119. ARGENTINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 120. ARGENTINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 121. ARGENTINA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 122. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 123. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 124. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 125. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 126. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 127. MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 128. MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 129. MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 130. MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 131. MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 132. GCC COUNTRIES INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 133. GCC COUNTRIES INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 134. GCC COUNTRIES INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 135. GCC COUNTRIES INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 136. GCC COUNTRIES INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 137. SOUTH AFRICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 138. SOUTH AFRICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 139. SOUTH AFRICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 140. SOUTH AFRICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 141. SOUTH AFRICA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 142. REST OF MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)

TABLE 143. REST OF MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 144. REST OF MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY GENDER, 2019-2035 (USD BILLIONS)

TABLE 145. REST OF MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)

TABLE 146. REST OF MEA INFERTILITY DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. NORTH AMERICA INFERTILITY DRUG MARKET ANALYSIS

FIGURE 3. US INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 4. US INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 5. US INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 6. US INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 7. US INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 8. CANADA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 9. CANADA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 10. CANADA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 11. CANADA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 12. CANADA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 13. EUROPE INFERTILITY DRUG MARKET ANALYSIS

FIGURE 14. GERMANY INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 15. GERMANY INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 16. GERMANY INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 17. GERMANY INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 18. GERMANY INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 19. UK INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 20. UK INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 21. UK INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 22. UK INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 23. UK INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 24. FRANCE INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 25. FRANCE INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 26. FRANCE INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 27. FRANCE INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 28. FRANCE INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 29. RUSSIA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 30. RUSSIA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 31. RUSSIA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 32. RUSSIA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 33. RUSSIA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 34. ITALY INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 35. ITALY INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 36. ITALY INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 37. ITALY INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 38. ITALY INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 39. SPAIN INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 40. SPAIN INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 41. SPAIN INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 42. SPAIN INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 43. SPAIN INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 44. REST OF EUROPE INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 45. REST OF EUROPE INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 46. REST OF EUROPE INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 47. REST OF EUROPE INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 48. REST OF EUROPE INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 49. APAC INFERTILITY DRUG MARKET ANALYSIS

FIGURE 50. CHINA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 51. CHINA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 52. CHINA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 53. CHINA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 54. CHINA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 55. INDIA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 56. INDIA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 57. INDIA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 58. INDIA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 59. INDIA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 60. JAPAN INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 61. JAPAN INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 62. JAPAN INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 63. JAPAN INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 64. JAPAN INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 65. SOUTH KOREA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 66. SOUTH KOREA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 67. SOUTH KOREA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 68. SOUTH KOREA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 69. SOUTH KOREA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 70. MALAYSIA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 71. MALAYSIA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 72. MALAYSIA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 73. MALAYSIA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 74. MALAYSIA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 75. THAILAND INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 76. THAILAND INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 77. THAILAND INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 78. THAILAND INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 79. THAILAND INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 80. INDONESIA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 81. INDONESIA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 82. INDONESIA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 83. INDONESIA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 84. INDONESIA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 85. REST OF APAC INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 86. REST OF APAC INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 87. REST OF APAC INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 88. REST OF APAC INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 89. REST OF APAC INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 90. SOUTH AMERICA INFERTILITY DRUG MARKET ANALYSIS

FIGURE 91. BRAZIL INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 92. BRAZIL INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 93. BRAZIL INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 94. BRAZIL INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 95. BRAZIL INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 96. MEXICO INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 97. MEXICO INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 98. MEXICO INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 99. MEXICO INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 100. MEXICO INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 101. ARGENTINA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 102. ARGENTINA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 103. ARGENTINA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 104. ARGENTINA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 105. ARGENTINA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 106. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 107. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 108. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 109. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 110. REST OF SOUTH AMERICA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 111. MEA INFERTILITY DRUG MARKET ANALYSIS

FIGURE 112. GCC COUNTRIES INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 113. GCC COUNTRIES INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 114. GCC COUNTRIES INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 115. GCC COUNTRIES INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 116. GCC COUNTRIES INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 117. SOUTH AFRICA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 118. SOUTH AFRICA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 119. SOUTH AFRICA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 120. SOUTH AFRICA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 121. SOUTH AFRICA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 122. REST OF MEA INFERTILITY DRUG MARKET ANALYSIS BY DRUG TYPE

FIGURE 123. REST OF MEA INFERTILITY DRUG MARKET ANALYSIS BY END USER

FIGURE 124. REST OF MEA INFERTILITY DRUG MARKET ANALYSIS BY GENDER

FIGURE 125. REST OF MEA INFERTILITY DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 126. REST OF MEA INFERTILITY DRUG MARKET ANALYSIS BY REGIONAL

FIGURE 127. KEY BUYING CRITERIA OF INFERTILITY DRUG MARKET

FIGURE 128. RESEARCH PROCESS OF MRFR

FIGURE 129. DRO ANALYSIS OF INFERTILITY DRUG MARKET

FIGURE 130. DRIVERS IMPACT ANALYSIS: INFERTILITY DRUG MARKET

FIGURE 131. RESTRAINTS IMPACT ANALYSIS: INFERTILITY DRUG MARKET

FIGURE 132. SUPPLY / VALUE CHAIN: INFERTILITY DRUG MARKET

FIGURE 133. INFERTILITY DRUG MARKET, BY DRUG TYPE, 2024 (% SHARE)

FIGURE 134. INFERTILITY DRUG MARKET, BY DRUG TYPE, 2019 TO 2035 (USD Billions)

FIGURE 135. INFERTILITY DRUG MARKET, BY END USER, 2024 (% SHARE)

FIGURE 136. INFERTILITY DRUG MARKET, BY END USER, 2019 TO 2035 (USD Billions)

FIGURE 137. INFERTILITY DRUG MARKET, BY GENDER, 2024 (% SHARE)

FIGURE 138. INFERTILITY DRUG MARKET, BY GENDER, 2019 TO 2035 (USD Billions)

FIGURE 139. INFERTILITY DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)

FIGURE 140. INFERTILITY DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)

FIGURE 141. INFERTILITY DRUG MARKET, BY REGIONAL, 2024 (% SHARE)

FIGURE 142. INFERTILITY DRUG MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)

FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS